765 related articles for article (PubMed ID: 19022818)
1. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
Kay J
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
[TBL] [Abstract][Full Text] [Related]
2. Nephrogenic systemic fibrosis: clinical picture and treatment.
Marckmann P; Skov L
Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
4. Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.
Bernstein EJ; Schmidt-Lauber C; Kay J
Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):489-503. PubMed ID: 23040363
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
Peak AS; Sheller A
Ann Pharmacother; 2007 Sep; 41(9):1481-5. PubMed ID: 17684032
[TBL] [Abstract][Full Text] [Related]
6. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
Boyd AS; Sanyal S; Abraham JL
J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
[TBL] [Abstract][Full Text] [Related]
7. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
Lim YL; Lee HY; Low SC; Chan LP; Goh NS; Pang SM
Clin Exp Dermatol; 2007 Jul; 32(4):353-8. PubMed ID: 17433041
[TBL] [Abstract][Full Text] [Related]
8. Nephrogenic systemic fibrosis: clinical spectrum of disease.
Mayr M; Burkhalter F; Bongartz G
J Magn Reson Imaging; 2009 Dec; 30(6):1289-97. PubMed ID: 19937929
[TBL] [Abstract][Full Text] [Related]
9. Nephrogenic systemic fibrosis.
Weinreb JC; Kuo PH
Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor.
Moreno-Romero JA; Segura S; Mascaró JM; Cowper SE; Julià M; Poch E; Botey A; Herrero C
Br J Dermatol; 2007 Oct; 157(4):783-7. PubMed ID: 17627792
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
Todd DJ; Kagan A; Chibnik LB; Kay J
Arthritis Rheum; 2007 Oct; 56(10):3433-41. PubMed ID: 17907148
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium and nephrogenic systemic fibrosis: have we overreacted?
Penfield JG; Reilly RF
Semin Dial; 2011; 24(5):480-6. PubMed ID: 21913988
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfate.
Kadiyala D; Roer DA; Perazella MA
Am J Kidney Dis; 2009 Jan; 53(1):133-7. PubMed ID: 19022548
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
Prasad SR; Jagirdar J
J Comput Assist Tomogr; 2008; 32(1):1-3. PubMed ID: 18303280
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
Wilford C; Fine JD; Boyd AS; Sanyal S; Abraham JL; Kantrow SM
Am J Dermatopathol; 2010 Feb; 32(1):71-5. PubMed ID: 19940755
[TBL] [Abstract][Full Text] [Related]
16. Safety of older generations of gadolinium in mild-to-moderate renal failure.
Khatami SM; Mahmoodian M; Zare E; Pashang M
Ren Fail; 2012; 34(2):176-80. PubMed ID: 22260266
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
Prince MR; Zhang HL; Prowda JC; Grossman ME; Silvers DN
Radiographics; 2009 Oct; 29(6):1565-74. PubMed ID: 19959508
[TBL] [Abstract][Full Text] [Related]
18. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
Kribben A; Witzke O; Hillen U; Barkhausen J; Daul AE; Erbel R
J Am Coll Cardiol; 2009 May; 53(18):1621-8. PubMed ID: 19406336
[TBL] [Abstract][Full Text] [Related]
19. Current status of nephrogenic systemic fibrosis.
Daftari Besheli L; Aran S; Shaqdan K; Kay J; Abujudeh H
Clin Radiol; 2014 Jul; 69(7):661-8. PubMed ID: 24582176
[TBL] [Abstract][Full Text] [Related]
20. [Nephrogenic systemic fibrosis and use of MR contrast media].
Christiansen RE; Sviland L; Sekse I; Svarstad E
Tidsskr Nor Laegeforen; 2009 Jan; 129(3):180-2. PubMed ID: 19180161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
